Soc. Generale Call 46 OMV 20.12.2.../ DE000SY1EB82 /
09/09/2024 21:48:42 | Chg.0.000 | Bid09/09/2024 | Ask09/09/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.017EUR | 0.00% | 0.017 Bid Size: 10,000 |
0.027 Ask Size: 10,000 |
OMV AG | 46.00 EUR | 20/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center